These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36430743)

  • 1. Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions.
    D'Alessandro VF; Takeshita A; Yasuma T; Toda M; D'Alessandro-Gabazza CN; Okano Y; Tharavecharak S; Inoue C; Nishihama K; Fujimoto H; Kobayashi T; Yano Y; Gabazza EC
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
    Li Y; Yan H; Wang F; Huang S; Zhang Y; Wang Z; Zhong M; Zhang W
    Biochem Biophys Res Commun; 2017 May; 486(3):693-699. PubMed ID: 28341121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus.
    Mallipattu SK; Gallagher EJ; LeRoith D; Liu R; Mehrotra A; Horne SJ; Chuang PY; Yang VW; He JC
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1008-17. PubMed ID: 24598803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
    Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.
    Tahara A; Takasu T
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):395-406. PubMed ID: 29374293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
    Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
    Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
    Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
    Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 12. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice.
    Kang YS; Lee MH; Song HK; Ko GJ; Kwon OS; Lim TK; Kim SH; Han SY; Han KH; Lee JE; Han JY; Kim HK; Cha DR
    Kidney Int; 2010 Nov; 78(9):883-94. PubMed ID: 20686445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
    Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of transient receptor potential melastatin 2 reduces renal fibrosis and inflammation by blocking transforming growth factor-β1-activated JNK1 activation in diabetic mice.
    Hu F; Yu Y; Lu F; Cheng X
    Aging (Albany NY); 2021 Nov; 13(22):24605-24620. PubMed ID: 34845114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
    Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
    Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
    Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
    Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jaceosidin Ameliorates Insulin Resistance and Kidney Dysfunction by Enhancing Insulin Receptor Signaling and the Antioxidant Defense System in Type 2 Diabetic Mice.
    Park E; Hong K; Kwon BM; Kim Y; Kim JH
    J Med Food; 2020 Oct; 23(10):1083-1092. PubMed ID: 32780673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.